A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Status:
Completed
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy and safety of enzalutamide treatment
in patients with progressive metastatic castration-resistant prostate cancer previously
treated with abiraterone acetate.